As of March 31, 2026, Exascale Labs Holdings Inc. has 63.20M shares outstanding.
| Shares Outstanding | 63.20M |
As of March 31, 2026, Exascale Labs Holdings Inc. maintains a current ratio of 0.28, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.28 |
| Quick Ratio | 0.11 |
These figures are as of the close on November 16, 2026.
| 50-Day Moving Average | 2.36 |
Over the twelve months ended March 31, 2026, Exascale Labs Holdings Inc. generated 11.70M in revenue and converted that into -9.42M in net income, yielding earnings per share of -0.16. EBITDA reached -3.43M, while operating income came in at -3.44M.
| Revenue | 11.70M |
| Gross Profit | 1.78M |
| Operating Income | -3.44M |
| Pretax Income | -9.42M |
| Net Income | -9.42M |
| EBITDA | -3.43M |
| EBIT | -3.44M |
| Earnings Per Share (EPS) | -0.16 |
These figures are as of March 31, 2026. Total book value stands at -20.91M, with working capital of -21.02M providing operational flexibility.
| Cash & Cash Equivalents | 984,830.00 |
| Net Debt | -984,830.00 |
| Equity (Book Value) | -20.91M |
| Book Value Per Share | -0.33 |
| Working Capital | -21.02M |
Over the twelve months ended March 31, 2026, Exascale Labs Holdings Inc. posted a gross margin of 15.19, reflecting its pricing power and cost economics. The operating margin of -29.39 and net profit margin of -80.47 provide insight into operational efficiency.
| Gross Margin | 15.19 |
| Operating Margin | -29.39 |
| Pretax Margin | -80.47 |
| Profit Margin | -80.47 |
| EBITDA Margin | -29.35 |